Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Citadel Embolization Device Study

NCT04057352 is registered in ClinicalTrials.gov with Stryker Neurovascular as lead sponsor.

NCT NCT04057352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04057352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Citadel Embolization Device Study
Lead sponsor
Stryker Neurovascular
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 18, 2019
Completion date
November 15, 2026
Enrollment
150 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

unruptured wide-neck aneurysms